Immediate Impact
1 from Science/Nature 70 standout
Citing Papers
New epilepsy therapies in development
2024 Standout
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele
2023 Standout
Works of P. Masel being referenced
Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection
2004
Nebulised dornase alpha: adherence in adults with cystic fibrosis
2002
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| P. Masel | 137 | 24 | 3 | 39 | 29 | 19 | 186 | |
| Alastair Reid | 174 | 41 | 28 | 19 | 25 | 14 | 263 | |
| Kay Tyerman | 80 | 19 | 47 | 25 | 16 | 20 | 247 | |
| Bryan Garcia | 143 | 16 | 41 | 91 | 18 | 17 | 251 | |
| Xingqi Deng | 68 | 59 | 18 | 93 | 18 | 15 | 266 | |
| Vesna Čukić | 153 | 70 | 26 | 24 | 26 | 24 | 276 | |
| Hiroshi Kawane | 100 | 74 | 28 | 88 | 20 | 22 | 254 | |
| Satish Haridasan | 31 | 34 | 14 | 39 | 28 | 24 | 233 | |
| Yong‐Kek Pang | 135 | 29 | 17 | 73 | 39 | 21 | 248 | |
| Rik De Decker | 142 | 32 | 51 | 79 | 11 | 23 | 261 | |
| Han-Pin Kuo | 119 | 61 | 57 | 64 | 39 | 17 | 276 |
All Works
Login with ORCID to disown or claim papers
Loading papers...